Global Preclinical Oncology Models Market is valued at USD 1335.7 Million in 2024 and is predicted to reach USD 3733.0 Million by 2034, at a 10.9% CAGR during the forecast period 2025-2034. The rise of immuno-oncology therapy such as T cell therapy, bispecific antibodies, immune checkpoint modulators, and personalized cancer vaccines compels the need for unique preclinical and translational service solution. Recently advances in Immuno-oncolog...
Report ID: 1093 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.5 Billion in 2024 and is predicted to reach 4.4 Billion by the year 2034 at a 11.9 % CAGR during the forecast period for 2025-2034. Global Cell and Gene Therapy Supply Chain/Logistics provides customizable services to support any stage of the supply chain, from the point of patient identification through cell harvest, therapeutic intervention, and long-term outcomes data c...
Report ID: 1694 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic activity (an essential endothelial cell mitogen and survival factor). It is the first anti-angiogenic therapy approved for the treatment of human cancer. The drug was developed by F. Hoffmann-La Roche AG...
Report ID: 1073 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 170
Global Medical Physics Market Size is valued at USD 5.16 Bn in 2023 and is predicted to reach USD 8.11 Bn by the year 2031 at an 5.9% CAGR during the forecast period for 2024 to 2031. Medical Physics Market Share & Trends Analysis Report, By Modality (Diagnostics (Radiographic X-Ray Systems, Fluoroscopic X-Ray Systems, Dental X-Ray Systems, Mammography Systems, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, SPECT, PET, Others),...
Report ID: 2901 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 172
Global Real-Time Prescription Drug Market Size is predicted to grow at an 14.8% CAGR during the forecast period for 2025 to 2034. Real-Time Prescription Drug Market Size, Share & Trends Analysis Distribution by Type (Software Platforms, Data Analytics Tools, and Hardware/IoT Integrations), by Application (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Payers/Insurance Providers, and Government Agencies), by Functionality (Prescrip...
Report ID: 3227 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Global Oral Proteins and Peptides Market Size is valued at USD 6.51 Bn in 2023 and is predicted to reach USD 28.17 Bn by the year 2031 at an 20.3% CAGR during the forecast period for 2024 to 2031. Oral Proteins and Peptides Market Share & Trends Analysis Report, By Type of Target Disease Indication (Acromegaly, Celiac Disease, Chronic Idiopathic Constipation, Enteric Hyperoxaluria, Inflammatory Bowel Disease, and Type II Diabetes), Type of M...
Report ID: 2868 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 170
Global Fibrotic Diseases Treatment Market Size is valued at USD 3.57 billion in 2023 and is predicted to reach USD 5.40 billion by the year 2031 at a 5.53% CAGR during the forecast period for 2024 to 2031. Fibrotic Diseases Treatment Market Size, Share & Trends Analysis Report By Treatment (Medication, Organ Transplantation, Oxygen Therapy, and Others), Application (Idiopathic Pulmonary Fibrosis, Hepatic Cirrhosis, Renal Fibrosis, Cutaneous ...
Report ID: 2876 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 165
HIV Drugs Market Size is valued at 39.29 Billion in 2024 and is predicted to reach 59.74 Billion by the year 2034 at a 4.4% CAGR during the forecast period for 2025-2034. Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV). The virus damages the immune system and thus interferes with the body’s ability to fight organisms that cause disease. HIV attacks immune cells, specifically CD-4 cells,...
Report ID: 1092 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 170
Molecular Pharming Market Size is valued at USD 1655.3 Mn in 2023 and is predicted to reach USD 3516.73 Mn by the year 2034 at a 8.1% CAGR during the forecast period for 2025-2034. In a biotechnological program known as "molecular farming," crops are genetically altered to create proteins and chemicals for industrial and pharmaceutical uses. The vast majority of developing nations cannot pay the enormous price of medical treatment...
Report ID: 1712 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Global NAD-based Anti-Aging Market is valued at USD 252.0 Million in 2024 and is predicted to reach USD 884.0 Million by the year 2034 at a 13.5% CAGR during the forecast period for 2025-2034. Nicotinamide adenine dinucleotide is crucial in all essential biological activities. When produced naturally, NAD+ may help to increase DNA damage repair, improve cognitive function, boost oxidative stress resistance, reduce inflammatio...
Report ID: 2284 |
Delivery: Immediate |
Published: September 2025 |
No. of Pages: 172
Pharmaceuticals